Citations (83)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Niccolò Bartalucci, Paola Guglielmelli & Alessandro M. Vannucchi. (2020) Polycythemia vera: the current status of preclinical models and therapeutic targets. Expert Opinion on Therapeutic Targets 24:7, pages 615-628.
Read now
Read now
Jan Jacques Michiels. (2017) Aspirin responsive erythromelalgia in JAK2-thrombocythemia and incurable inherited erythrothermalgia in neuropathic Nav1.7 sodium channelopathy: from Mitchell 1878 to Michiels 2017. Expert Opinion on Orphan Drugs 5:2, pages 111-129.
Read now
Read now
Chad C Cherington, Krisstina L Gowin & Ruben A Mesa. (2015) Ruxolitinib for treatment of polycythemia vera. Expert Opinion on Orphan Drugs 3:9, pages 1085-1096.
Read now
Read now
Eduardo Arellano-Rodrigo, Alberto Alvarez-Larrán, Juan Carlos Reverter, Neus Villamor, Josep Maria Jou & Francisco Cervantes. (2012) Automated assessment of the neutrophil and platelet activation status in patients with essential thrombocythemia. Platelets 23:5, pages 336-343.
Read now
Read now
H X Guo, G C Chan, A K Chiang, M H Ho, E Y T Chan & S Y Ha. (2012) Dural sinus thrombosis owing to polycythaemia vera in a 12-year-old girl. Paediatrics and International Child Health 32:3, pages 167-170.
Read now
Read now
S. Caner Karahan, Mehmet Sonmez, Fatma Saglam, Ahmet Mentese, Nergiz Erkut, Murat Topbas, Muge Kopuz & Umit Cobanoglu. (2010) Can ischemia-modified albumin be a valuable indicator of tissue ischemia in polycythemia vera?. Hematology 15:3, pages 151-156.
Read now
Read now
Judit Toth, Janos Kappelmayer, Miklos L. Udvardy, Timea Szanto, Mariann Szarvas, Laszlo Rejto, Pal Soltesz, Miklos Udvardy & Jolan Harsfalvi. (2009) Increased platelet glycoprotein Ib receptor number, enhanced platelet adhesion and severe cerebral ischaemia in a patient with polycythaemia vera. Platelets 20:4, pages 282-287.
Read now
Read now
Articles from other publishers (76)
Ayalew Tefferi & Tiziano Barbui. (2023) Polycythemia vera: 2024 update on diagnosis, risk‐stratification, and management. American Journal of Hematology 98:9, pages 1465-1487.
Crossref
Crossref
Cerci Kubra & Patir Pusem. (2023) Ruxolitinib as a therapy choice for refractory pruritus in a patient with essential thrombocythemia with CALR mutation. Global Journal of Medical and Clinical Case Reports 10:1, pages 001-002.
Crossref
Crossref
Marco Cattaneo. (2023) Aspirin in essential thrombocythemia. For whom? What formulation? What regimen?. Haematologica 108:6, pages 1487-1499.
Crossref
Crossref
Vincent Ernest, Norman Abbou, Antoine Tichadou, Robin Arcani & Geoffroy Venton. (2023) Characteristics of JAK2 unmutated erythrocytosis: Distinctive traits between polycythemia vera and non-polycythemia vera patients. European Journal of Internal Medicine 107, pages 113-115.
Crossref
Crossref
Jürgen P. Bauerschmitz. 2020. Klinische Angiologie. Klinische Angiologie
1
10
.
Judith A. Paice & Jonathan Moreira. 2023. Palliative Care in Hematologic Malignancies and Serious Blood Disorders. Palliative Care in Hematologic Malignancies and Serious Blood Disorders
153
167
.
Takashi Shimoyama, Hiroki Yamaguchi, Kazumi Kimura, Fumiaki Suzuki, Toshiyuki Hayashi & Satoshi Wakita. (2022) Clinical characteristics and management of headache in patients with myeloproliferative neoplasms. Frontiers in Neurology 13.
Crossref
Crossref
Huajun Yang, Chengxuan Qi, Fang Su, Wei Shan, Anchen Guo, Jianping Wu, Yongjun Wang, Hong You & Qun Wang. (2022) Cerebral Ischemia/Reperfusion Injury and Pharmacologic Preconditioning as a Means to Reduce Stroke-induced Inflammation and Damage. Neurochemical Research 47:12, pages 3598-3614.
Crossref
Crossref
Ivan Krecak, Marko Lucijanic & Srdan Verstovsek. (2022) Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia. Current Hematologic Malignancy Reports 17:5, pages 155-169.
Crossref
Crossref
Marco Burattini, Lorenzo Falsetti, Eleonora Potente, Claudia Rinaldi, Marco Bartolini, Laura Buratti, Mauro Silvestrini & Giovanna Viticchi. (2022) Ischemic stroke as a presenting manifestation of polycythemia vera: a narrative review. Reviews in the Neurosciences 33:3, pages 303-311.
Crossref
Crossref
Ayalew Tefferi, Alessandro M. Vannucchi & Tiziano Barbui. (2021) Polycythemia vera: historical oversights, diagnostic details, and therapeutic views. Leukemia 35:12, pages 3339-3351.
Crossref
Crossref
Chiara Trotti, Emanuela Sant’Antonio, Daniele Vanni, Ilaria Carola Casetti, Oscar Borsani, Daniela Pietra, Virginia Valeria Ferretti, Cesare Astori, Luca Arcaini & Elisa Rumi. (2021) Acquired von Willebrand syndrome in myeloproliferative neoplasms with extreme thrombocytosis. Hematological Oncology 39:4, pages 589-592.
Crossref
Crossref
Ya-Yun Cao, Jie Cao, Zhua-Jin Bi, Sha-Bei Xu & Chen-Chen Liu. (2021) Hemorrhagic transformation after acute ischemic stroke caused by polycythemia vera: Report of two case. World Journal of Clinical Cases 9:25, pages 7551-7557.
Crossref
Crossref
Andrew J. RobinsonAnna L. Godfrey. (2021) Low-Risk Essential Thrombocythemia: A Comprehensive Review. HemaSphere 5:2, pages e521.
Crossref
Crossref
Kyung Chul Moon, Jeong-An Gim, Dae Sik Kim, Chul Won Choi, Jung Yoon & Soo-Young Yoon. (2021) Total Platelet Transcriptomics and Its Network Analysis by RNA-Seq and miRNA-Seq and PCA Application in Essential Thrombocythaemia. Acta Haematologica 144:3, pages 337-344.
Crossref
Crossref
Á. Gómez-Camello. (2021) Cefalea numular y policitemia vera. Neurology Perspectives 1:1, pages 107-108.
Crossref
Crossref
Giacomo Coltro, Giuseppe G. Loscocco & Alessandro M. Vannucchi. 2021. Cellular and Molecular Aspects of Myeloproliferative Neoplasms - Part A. Cellular and Molecular Aspects of Myeloproliferative Neoplasms - Part A
1
69
.
Veronika Buxhofer-Ausch, Sonja Heibl, Thamer Sliwa, Christine Beham-Schmid, Dominik Wolf, Klaus Geissler, Maria Theresa Krauth, Peter Krippl, Andreas Petzer, Albert Wölfler, Thomas Melchardt & Heinz Gisslinger. (2020) Austrian recommendations for the management of essential thrombocythemia. Wiener klinische Wochenschrift 133:1-2, pages 52-61.
Crossref
Crossref
Ayalew Tefferi & Tiziano Barbui. (2020) Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk‐stratification and management. American Journal of Hematology 95:12, pages 1599-1613.
Crossref
Crossref
Jasmina Boban, Peter Kalhs & Majda M. Thurnher. (2019) Cerebral intraparenchymal extramedullary hematopoiesis in polycythemia vera. Acta Neurologica Belgica 120:5, pages 1181-1183.
Crossref
Crossref
Alessandra Iurlo, Daniele Cattaneo, Cristina Bucelli & Luca Baldini. (2020) New Perspectives on Polycythemia Vera: From Diagnosis to Therapy. International Journal of Molecular Sciences 21:16, pages 5805.
Crossref
Crossref
Hassan Awada, Maria Voso, Paola Guglielmelli & Carmelo Gurnari. (2020) Essential Thrombocythemia and Acquired von Willebrand Syndrome: The Shadowlands between Thrombosis and Bleeding. Cancers 12:7, pages 1746.
Crossref
Crossref
Swapnil Raut, Upasna Singh, Deepaneeta Sarmah, Aishika Datta, Falguni Baidya, Birva Shah, Mariya Bohra, Priya Jagtap, Ankan Sarkar, Kiran Kalia, Anupom Borah, Kunjan R. Dave, Dileep R. Yavagal & Pallab Bhattacharya. (2020) Migraine and Ischemic Stroke: Deciphering the Bidirectional Pathway. ACS Chemical Neuroscience 11:11, pages 1525-1538.
Crossref
Crossref
Michiels Jan Jacques, Lam King H, Kate Fibo Ten, Kim Dong-Wook, Kim Myungshin, Shuvaev Vasily, Valster Francisca, Potters Vincent, Schroyens Wilfried, Andreescu Mihaela, Trifa Adrian, Pich Achille & De Raeve Hendrik. (2020) Novel European Asiatic Clinical, Laboratory, Molecular and Pathobiological (2015-2020 CLMP) criteria for JAK2V617F trilinear polycythemia vera (PV), JAK2exon12 PV and JAK2V617F, CALR and MPL515 thrombocythemias: From Dameshek to Constantinescu-Vainchenker, Kralovics and Michiels. International Journal of Bone Marrow Research 3:1, pages 001-020.
Crossref
Crossref
Charlotte Liisborg, Hans Carl Hasselbalch & Torben Lykke Sørensen. (2020) Ocular Manifestations in Patients with Philadelphia-Negative Myeloproliferative Neoplasms. Cancers 12:3, pages 573.
Crossref
Crossref
Jerry L. Spivak. (2019) How I treat polycythemia vera. Blood 134:4, pages 341-352.
Crossref
Crossref
Ayalew Tefferi & Tiziano Barbui. (2019) Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management. American Journal of Hematology 94:1, pages 133-143.
Crossref
Crossref
M. M. Tanashyan, P. I. Kuznetsova, A. A. Shabalina & A. A. Raskurazhev. (2019) Prevention of Cerebrovascular Disease in Patients with Myeloproliferatie Disorders. Human Physiology 44:8, pages 896-900.
Crossref
Crossref
Gabriela Trifan, Neelofer Shafi & Fernando D. Testai. (2018) Implications of Janus Kinase 2 Mutation in Embolic Stroke of Unknown Source. Journal of Stroke and Cerebrovascular Diseases 27:10, pages 2572-2578.
Crossref
Crossref
Sonja Burgstaller, Veronika Buxhofer-Ausch, Thamer Sliwa, Christine Beham-Schmid, Günther Gastl, Klaus Geissler, Thomas Melchardt, Maria Krauth, Peter Krippl, Andreas Petzer, Holger Rumpold, Albert Wölfler & Heinz Gisslinger. (2018) Austrian recommendations for the management of polycythemia vera. Wiener klinische Wochenschrift 130:17-18, pages 535-542.
Crossref
Crossref
Rafał Małecki, Małgorzata Gacka, Żanna Fiodorenko-Dumas, Ilias Dumas, Jacek Kwiatkowski, Rajmund Adamiec & Małgorzata Kuliszkiewicz-Janus. (2018) Peripheral circulatory disorders in essential thrombocythemia. Microvascular Research 116, pages 15-19.
Crossref
Crossref
Valerio De Stefano, Alessandra Carobbio, Vincenzo Di Lazzaro, Paola Guglielmelli, Alessandra Iurlo, Maria Chiara Finazzi, Elisa Rumi, Francisco Cervantes, Elena Maria Elli, Maria Luigia Randi, Martin Griesshammer, Francesca Palandri, Massimiliano Bonifacio, Juan-Carlos Hernandez-Boluda, Rossella Cacciola, Palova Miroslava, Giuseppe Carli, Eloise Beggiato, Martin H. Ellis, Caterina Musolino, Gianluca Gaidano, Davide Rapezzi, Alessia Tieghi, Francesca Lunghi, Giuseppe Gaetano Loscocco, Daniele Cattaneo, Agostino Cortelezzi, Silvia Betti, Elena Rossi, Guido Finazzi, Bruno Censori, Mario Cazzola, Marta Bellini, Eduardo Arellano-Rodrigo, Irene Bertozzi, Parvis Sadjadian, Nicola Vianelli, Luigi Scaffidi, Montse Gomez, Emma Cacciola, Alessandro M. Vannucchi & Tiziano Barbui. (2018) Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms. Blood Cancer Journal 8:3.
Crossref
Crossref
Sarah Hintermair, Elisabeth Zwickl-Traxler, Martin Pecherstorfer & Josef Singer. (2018) Evaluation of vascular events in patients with myeloproliferative syndromes and mutations of either the januskinase-2 or calreticulin gene at the university hospital Krems from 2008 to 2015. Oncotarget 9:9, pages 8450-8462.
Crossref
Crossref
Jerry L. Spivak. (2018) Polycythemia Vera. Current Treatment Options in Oncology 19:2.
Crossref
Crossref
Joseph J. Shatzel, Robyn Scherber & Thomas G. DeLoughery. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
1263
1289
.
L Falchi, H M Kantarjian & S Verstovsek. (2017) Assessing the thrombotic risk of patients with essential thrombocythemia in the genomic era. Leukemia 31:9, pages 1845-1854.
Crossref
Crossref
Lubna Zafar, Feroz Alam, Anjum Parvez & Srikant Behera. (2017) BCR/ABL positive thrombocythemia: a diagnostic dilemma. The Egyptian Journal of Internal Medicine 29:2, pages 83-85.
Crossref
Crossref
Anne Willerslev, Mathias M. Hansen, Oliver Niels Klefter, Ole Weis Bjerrum, Hans C. Hasselbalch, Stine N. Clemmensen, Michael Larsen & Inger Christine Munch. (2016) Non‐invasive imaging of retinal blood flow in myeloproliferative neoplasms. Acta Ophthalmologica 95:2, pages 146-152.
Crossref
Crossref
Lorenzo Falchi, Prithviraj Bose, Kate J. Newberry & Srdan Verstovsek. (2017) Approach to patients with essential thrombocythaemia and very high platelet counts: what is the evidence for treatment?. British Journal of Haematology 176:3, pages 352-364.
Crossref
Crossref
Brandi Reeves & Stephan Moll. 2017. Practical Hemostasis and Thrombosis. Practical Hemostasis and Thrombosis
210
228
.
Jan Jacques Michiels. (2017) Aspirin cures erythromelalgia and cerebrovascular disturbances in JAK2-thrombocythemia through platelet-cycloxygenase inhibition. World Journal of Hematology 6:3, pages 32.
Crossref
Crossref
Ayalew Tefferi & Tiziano Barbui. (2017) Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management. American Journal of Hematology 92:1, pages 94-108.
Crossref
Crossref
Marine M. Tanashyan, Polina I. Kuznetsova, Alla A. Shabalina, Anton A. Raskurazhev, Olga V. Lagoda, Irina N. Subortseva & Anait L. Melikyan. (2016) Clinical Characteristics of Cerebrovascular Pathology with Patients Suffering from Ph-Negative Myeloproliferative Disease. Cerebrovascular Diseases Extra 6:3, pages 66-70.
Crossref
Crossref
Andreas R. Luft. (2016) Closing PFO closure for migraine?. European Heart Journal 37:26, pages 2037-2039.
Crossref
Crossref
Andrea Aroldi, Caterina Cecchetti, Arianna Colombo, Leonardo Cattaneo, Pietro Enrico Pioltelli, Enrico Maria Pogliani & Elena Maria Elli. (2016) Neurological symptoms in essential thrombocythemia: impact of JAK2V617F mutation and response to therapy. European Journal of Haematology 96:6, pages 593-601.
Crossref
Crossref
XINGZHI LI, YAOMIN LI, YAO QU & LAIJIN LU. (2016) Secondary erythromelalgia successfully treated with patient-controlled epidural analgesia and interferon α-2b: A case report and review of the literature. Experimental and Therapeutic Medicine 11:5, pages 1823-1826.
Crossref
Crossref
Brady L. Stein. 2016. Managing Myeloproliferative Neoplasms. Managing Myeloproliferative Neoplasms
172
177
.
Celia Beynon, Gwenan Huws & Tom Lawson. (2016) Myeloproliferative Disease: An Unusual Cause of Raynaud’s Phenomenon and Digital Ischaemia. Case Reports in Medicine 2016, pages 1-2.
Crossref
Crossref
Catherine Strassel, Lucia Kubovcakova, Pierre H. Mangin, Catherine Ravanat, Monique Freund, Radek C. Skoda, Cécile V. Denis, Arnaud Dupuis, Raoul Herbrecht, Christian Gachet & François Lanza. (2017) Haemorrhagic and thrombotic diatheses in mouse models with thrombocytosis. Thrombosis and Haemostasis 113:02, pages 414-425.
Crossref
Crossref
Jerome Mawet, Tobias Kurth & Cenk Ayata. (2014) Migraine and stroke: In search of shared mechanisms. Cephalalgia 35:2, pages 165-181.
Crossref
Crossref
Ayalew Tefferi & Tiziano Barbui. (2015) Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management. American Journal of Hematology 90:2, pages 162-173.
Crossref
Crossref
Kyu-Sun ChoiJae-Min KimJe-Il RyuYoung-Ha Oh. (2015) Concurrent Ruptured Pseudoaneurysm of the Internal Carotid Artery and Cerebral Infarction as an Initial Manifestation of Polycythemia Vera. Journal of Korean Neurosurgical Society 58:2, pages 137.
Crossref
Crossref
Jan Jacques Michiels, Achille Pich, Hendrik De Raeve & Alain Gadisseur. (2015) Essential Differences in Clinical and Bone Marrow Features in <b><i>BCR/ABL-</i></b>Positive Thrombocythemia Compared to Thrombocythemia in the <b><i>BCR/ABL</i></b>-Negative Myeloproliferative Neoplasms Essential Thrombocythemia and Polycythemia Vera. Acta Haematologica 133:1, pages 52-55.
Crossref
Crossref
Michael Medinger, Patricia Muesser, Sabine Girsberger, Radek Skoda, Alexandar Tzankov, Andreas Buser, Jakob Passweg & Dimitrios Α. Tsakiris. (2014) Dkk3 levels in patients with myeloproliferative neoplasms. Thrombosis Research 133:2, pages 218-221.
Crossref
Crossref
João Forjaz de Lacerda, Sofia N. Oliveira & José M. Ferro. 2014. Neurologic Aspects of Systemic Disease Part II. Neurologic Aspects of Systemic Disease Part II
1073
1081
.
Marina Panova-Noeva, Marina Marchetti, Laura Russo, Carmen J. Tartari, Anna Leuzzi, Guido Finazzi, Alessandro Rambaldi, Hugo ten Cate & Anna Falanga. (2013) ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia Vera. Thrombosis Research 132:1, pages 88-93.
Crossref
Crossref
Ayalew Tefferi. (2013) Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk‐stratification, and management. American Journal of Hematology 88:6, pages 507-516.
Crossref
Crossref
Carlo Patrono, Bianca Rocca & Valerio De Stefano. (2013) Platelet activation and inhibition in polycythemia vera and essential thrombocythemia. Blood 121:10, pages 1701-1711.
Crossref
Crossref
Ayalew Tefferi. (2012) Myeloproliferative neoplasms 2012: The John M. Bennett 80th birthday anniversary lecture. Leukemia Research 36:12, pages 1481-1489.
Crossref
Crossref
Ayalew Tefferi. (2012) Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management. American Journal of Hematology 87:3, pages 284-293.
Crossref
Crossref
Tobias Kurth, Hugues Chabriat & Marie-Germaine Bousser. (2012) Migraine and stroke: a complex association with clinical implications. The Lancet Neurology 11:1, pages 92-100.
Crossref
Crossref
Michael Ronthal. 2012. Neurology in Clinical Practice. Neurology in Clinical Practice
340
348
.
Subhraleena Das, Hatim Karachiwala, Sujith V. Cherian, Amarinder S. Garcha, Sushama Jasti & Ajeet Gajra. (2011) Anticoagulant-resistant thrombophilia in a patient with polycythemia vera. Blood Coagulation & Fibrinolysis 22:8, pages 746-748.
Crossref
Crossref
Marina Panova‐Noeva, Marina Marchetti, Henri Maria Spronk, Laura Russo, Erika Diani, Good Finazzi, Silvia Salmoiraghi, Aueesandrd Rambaldi, Titiano Barbui, Huao Ten Cate & Anna Falanga. (2011) Platelet‐induced thrombin generation by the calibrated automated thrombogram assay is increased in patients with essential thrombocythemia and polycythemia vera. American Journal of Hematology 86:4, pages 337-342.
Crossref
Crossref
Ayalew Tefferi. (2011) Annual Clinical Updates in Hematological Malignancies: A Continuing Medical Education Series: Polycythemia vera and essential thrombocythemia: 2011 update on diagnosis, risk-stratification, and management. American Journal of Hematology 86:3, pages 292-301.
Crossref
Crossref
. 2011. Andrews' Diseases of the Skin. Andrews' Diseases of the Skin
801
845
.
Turgay Dalkara, Ala Nozari & Michael A Moskowitz. (2010) Migraine aura pathophysiology: the role of blood vessels and microembolisation. The Lancet Neurology 9:3, pages 309-317.
Crossref
Crossref
Ala Nozari, Ergin Dilekoz, Inna Sukhotinsky, Thor Stein, Katharina Eikermann‐Haerter, Christina Liu, Yumei Wang, Matthew P. Frosch, Christian Waeber, Cenk Ayata & Michael A. Moskowitz. (2010) Microemboli may link spreading depression, migraine aura, and patent foramen ovale. Annals of Neurology 67:2, pages 221-229.
Crossref
Crossref
Lisa Pleyer, Victoria Faber, Daniel Neureiter, Daniel Neureiter & Richard Greil. 2010. Chronic Myeloid Neoplasias and Clonal Overlap Syndromes. Chronic Myeloid Neoplasias and Clonal Overlap Syndromes
15
50
.
Gretchen E. Tietjen & Jagdish Khubchandani. (2009) Platelet dysfunction and stroke in the female migraineur. Current Pain and Headache Reports 13:5, pages 386-391.
Crossref
Crossref
Itshak Melzer, Roni Marx & Ilan Kurz. (2009) Regular Exercise in the Elderly Is Effective to Preserve the Speed of Voluntary Stepping under Single-Task Condition but Not under Dual-Task Condition. Gerontology 55:1, pages 49-57.
Crossref
Crossref
Francesca SantilliMario RomanoAntonio RecchiutiAlfredo Dragani, Angela FalcoGianfranco LessianiFrancesca Fioritoni, Stefano LattanzioDomenico MattoscioRaimondo De Cristofaro, Bianca RoccaGiovanni Davì. (2008) Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. Blood 112:4, pages 1085-1090.
Crossref
Crossref
Naohide Watanabe, Laurent Bodin, Manjula Pandey, Matthias Krause, Shaun Coughlin, Vassiliki A. Boussiotis, Mark H. Ginsberg & Sanford J. Shattil. (2008) Mechanisms and consequences of agonist-induced talin recruitment to platelet integrin αIIbβ3. The Journal of Cell Biology 181:7, pages 1211-1222.
Crossref
Crossref
C. Masson, B. Bouvard & M. Audran. (2008) Reumatismos intermitentes (con excepción de los síndromes autoinflamatorios). EMC - Aparato Locomotor 41:2, pages 1-8.
Crossref
Crossref
C. Masson, B. Bouvard & M. Audran. (2008) Rhumatismes intermittents (en dehors des syndromes auto-inflammatoires). EMC - Appareil locomoteur 3:1, pages 1-7.
Crossref
Crossref
E Gretchen & MD Tietjen. (2016) Migraine and Ischaemic Heart Disease and Stroke: Potential Mechanisms and Treatment Implications. Cephalalgia 27:8, pages 981-987.
Crossref
Crossref